A detailed history of First Trust Advisors LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, First Trust Advisors LP holds 337,027 shares of JAZZ stock, worth $41.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
337,027
Previous 234,688 43.61%
Holding current value
$41.7 Million
Previous $25 Million 49.97%
% of portfolio
0.04%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.57 - $116.37 $10.3 Million - $11.9 Million
102,339 Added 43.61%
337,027 $37.6 Million
Q2 2024

Aug 13, 2024

BUY
$103.94 - $118.98 $10.3 Million - $11.7 Million
98,666 Added 72.54%
234,688 $25 Million
Q1 2024

May 13, 2024

BUY
$115.19 - $132.77 $1.98 Million - $2.29 Million
17,219 Added 14.49%
136,022 $16.4 Million
Q4 2023

Feb 13, 2024

BUY
$114.26 - $136.0 $7.35 Million - $8.75 Million
64,340 Added 118.14%
118,803 $14.6 Million
Q3 2023

Nov 13, 2023

BUY
$122.0 - $145.31 $5.41 Million - $6.44 Million
44,338 Added 437.91%
54,463 $7.05 Million
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $4.89 Million - $5.88 Million
-39,944 Reduced 79.78%
10,125 $1.26 Million
Q1 2023

May 15, 2023

SELL
$133.98 - $160.47 $2.14 Million - $2.57 Million
-16,002 Reduced 24.22%
50,069 $7.33 Million
Q4 2022

Feb 09, 2023

BUY
$129.72 - $159.85 $8.04 Million - $9.91 Million
62,016 Added 1529.37%
66,071 $10.5 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $57,725 - $73,498
-456 Reduced 10.11%
4,055 $541,000
Q2 2022

Aug 12, 2022

SELL
$141.59 - $168.66 $10.7 Million - $12.7 Million
-75,533 Reduced 94.36%
4,511 $703,000
Q1 2022

May 13, 2022

BUY
$129.64 - $160.7 $3.43 Million - $4.25 Million
26,446 Added 49.34%
80,044 $12.5 Million
Q4 2021

Feb 08, 2022

SELL
$119.87 - $145.67 $13.3 Million - $16.1 Million
-110,552 Reduced 67.35%
53,598 $6.83 Million
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $2.53 Million - $3.64 Million
-19,689 Reduced 10.71%
164,150 $21.4 Million
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $12.4 Million - $14.4 Million
77,334 Added 72.61%
183,839 $32.7 Million
Q1 2021

May 14, 2021

BUY
$150.19 - $173.5 $8.96 Million - $10.4 Million
59,670 Added 127.4%
106,505 $17.5 Million
Q4 2020

Feb 02, 2021

SELL
$140.71 - $165.05 $13.7 Million - $16.1 Million
-97,625 Reduced 67.58%
46,835 $7.73 Million
Q3 2020

Nov 05, 2020

SELL
$105.46 - $144.13 $8.7 Million - $11.9 Million
-82,526 Reduced 36.36%
144,460 $20.6 Million
Q2 2020

Jul 22, 2020

SELL
$95.68 - $121.88 $6.34 Million - $8.08 Million
-66,309 Reduced 22.61%
226,986 $25 Million
Q1 2020

May 06, 2020

BUY
$87.74 - $152.74 $6.05 Million - $10.5 Million
68,992 Added 30.76%
293,295 $29.3 Million
Q4 2019

Feb 03, 2020

BUY
$117.65 - $153.73 $8.48 Million - $11.1 Million
72,080 Added 47.35%
224,303 $33.5 Million
Q3 2019

Nov 04, 2019

BUY
$125.18 - $143.24 $3.43 Million - $3.92 Million
27,373 Added 21.92%
152,223 $19.5 Million
Q2 2019

Jul 30, 2019

SELL
$125.55 - $144.48 $11.3 Million - $13 Million
-89,659 Reduced 41.8%
124,850 $17.8 Million
Q1 2019

May 09, 2019

BUY
$121.81 - $142.95 $7.48 Million - $8.78 Million
61,424 Added 40.12%
214,509 $30.7 Million
Q4 2018

Feb 07, 2019

BUY
$115.94 - $166.74 $4.24 Million - $6.1 Million
36,603 Added 31.42%
153,085 $19 Million
Q3 2018

Oct 25, 2018

BUY
$161.01 - $180.57 $15.1 Million - $16.9 Million
93,748 Added 412.37%
116,482 $19.6 Million
Q2 2018

Aug 02, 2018

BUY
$146.33 - $183.18 $2.45 Million - $3.07 Million
16,768 Added 281.06%
22,734 $3.92 Million
Q1 2018

Apr 23, 2018

BUY
$135.59 - $157.16 $808,929 - $937,616
5,966 New
5,966 $901,000
Q4 2017

Feb 08, 2018

SELL
$131.06 - $150.39 $1.88 Million - $2.15 Million
-14,310 Closed
0 $0
Q3 2017

Oct 24, 2017

BUY
$142.62 - $155.6 $2.04 Million - $2.23 Million
14,310
14,310 $2.09 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.76B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.